Arashdeep Singh
banner
arash-singh.bsky.social
Arashdeep Singh
@arash-singh.bsky.social
Nutrition and Metabolism Scientist 🧠
Reposted by Arashdeep Singh
Identifying GLP-1 receptor therapy as a first-in-class treatment for Bardet-Biedl syndrome—

Guillaume de Lartigue & team show treatment with semaglutide reduced eating/weight gain, and improved glucose tolerance and cognitive behavior in a BBS mouse model: buff.ly/4F0fcqZ
June 17, 2025 at 1:20 PM
Reposted by Arashdeep Singh
ICYMI:
Identifying GLP-1 receptor therapy as a first-in-class treatment for Bardet-Biedl syndrome—

Guillaume de Lartigue & team show treatment with semaglutide reduced eating/weight gain, and improved glucose tolerance and cognitive behavior in a BBS mouse model: buff.ly/4F0fcqZ
June 22, 2025 at 12:04 PM
Reposted by Arashdeep Singh
Christmas has come early....SSIBlings in a box!

#SSIB2025 Oxford, UK
August 4, 2025 at 2:09 AM